Login / Signup

Positive effects of ocrelizumab in patients with familial mediterranean fever and coexistent multiple sclerosis.

Caner Feyzi DemirFerhat BALGETiREthemoglu OzlemDürdane Bekar AksoyFiliz DemirdögenSuleyman Serdar KocaMehmet Fatih Yetkinİrem Taşcı
Published in: Archives of rheumatology (2021)
Ocrelizumab therapy led to a prominent decrease in the frequency of FMF attacks, alleviated functional impairment, and improved quality of life in MS+FMF patients.
Keyphrases
  • multiple sclerosis
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • mass spectrometry
  • peritoneal dialysis
  • stem cells
  • patient reported outcomes
  • bone marrow
  • patient reported